Media type: E-Article Title: Permanent dose reduction due to adverse reactions does not decrease efficacy of BRAF/MEK inhibition in metastatic melanoma Contributor: Buchacher, Lukas; Richtig, Georg; Dernoscheg, Marie; Richtig, Erika; Koch, Lukas imprint: Wiley, 2023 Published in: Journal of the European Academy of Dermatology and Venereology Language: English DOI: 10.1111/jdv.18871 ISSN: 0926-9959; 1468-3083 Keywords: Infectious Diseases ; Dermatology Origination: Footnote: